#USA #Memphis #Neurological Disorders #St. Jude #Carsten Bönnemann

St. Jude Children's Research Hospital Welcomes Notable Clinician-Scientist

St. Jude Children's Research Hospital in Memphis, Tennessee, has recently announced an important addition to its team: Dr. Carsten Bönnemann. He will be leading and chairing the newly established Department of Genomic and Translational Neuroscience. This department aims to push the boundaries of research into pediatric catastrophic neurological disorders. With a reputation as a world-renowned clinician-scientist, Dr. Bönnemann brings an impressive background in pediatric neuromuscular and neurogenetic disorders from his previous role at the National Institutes of Health (NIH).

Pioneering Research Background

During his time at the NIH, Dr. Bönnemann made significant contributions to the understanding of genetic causes associated with juvenile amyotrophic lateral sclerosis and other neuromuscular disorders. He pioneered groundbreaking work, including the first in-human application of AAV gene therapy for treating giant axonal neuropathy. His expertise is poised to enhance St. Jude’s ability to uncover the fundamental genetic and molecular bases of devastating neurological conditions.

In his own words, Dr. Bönnemann expressed great enthusiasm about his new role by stating, "Joining St. Jude is an extraordinary opportunity to accelerate discoveries for children with catastrophic neurological disorders. The mission of this new department is to understand the unique genetic and molecular roots of these devastating disorders and conceptualize genetic precision therapies based on this knowledge."

This vision aligns seamlessly with the mission of St. Jude Children's Research Hospital, which is dedicated to improving the treatment landscape for children managing complex neurological conditions. By employing cutting-edge scientific approaches, the department aims to foster research collaboration across various disciplines, pushing the limits of discovery and therapeutic innovations.

A New Department with an Ambitious Mission

The Department of Genomic and Translational Neuroscience is designed as an extension of St. Jude’s commitment to pediatric neuroscience. It encompasses key initiatives, including the Pediatric Translational Neuroscience Initiative, and integrates both basic and clinical research efforts. The department aims not only to advance scientific understanding but also to enhance the quality of life for pediatric patients through preclinical and clinical research.

One of the primary components under this department is the Center for Pediatric Neurological Disease Research (CPNDR), which drives foundational research into complex pediatric neurological conditions. Alongside it is the Center for Experimental Neurotherapeutics (CENT), which focuses on hastening the clinical development of promising new treatment strategies, emphasizing genomic diagnosis and precision-targeted therapies.

Building a Stellar Team

Dr. Bönnemann will be surrounded by a talented group of faculty members specializing in various aspects of pediatric neurology. The team includes notable experts like Fernando Alsina, PhD; Xiaoyu Chen, PhD; Richard Finkel, MD; Andrea Gropman, MD; and others. Together, they will tackle some of the most challenging aspects of catastrophic neurological diseases, which are known to be rare, aggressive, and biologically intricate.

J. Paul Taylor, MD, PhD, who serves as executive vice president and director of the Pediatric Translational Neuroscience Initiative at St. Jude, highlighted the unique structure of St. Jude, stating, "What makes St. Jude unique is the integration of different disciplines — laboratory discovery, therapy development, manufacturing, and clinical delivery — all happening under one roof."

This integration is crucial for generating effective therapies that target the root causes of these rare and ultra-rare conditions, ultimately providing hope where options may be limited.

Dr. Bönnemann's Academic Credentials

Dr. Bönnemann’s impressive academic credentials include medical training at the Albert-Ludwigs University in Freiburg, Germany. He completed his residency in pediatric neurology at Massachusetts General Hospital and the Harvard Medical School, followed by a fellowship in neuromuscular neurology at Boston Children's Hospital. His postdoctoral work included exploring the molecular genetics of muscular dystrophy. His exemplary contributions to research have earned him several significant awards, reflecting his dedication and impact in the field.

St. Jude's Commitment to Children

At the heart of St. Jude's mission is a dedication to treating and curing childhood catastrophic diseases. Through its groundbreaking research and compassionate care, St. Jude seeks to ensure that children worldwide have the best chance at a healthy future. By embracing innovative science and fostering global collaborations, St. Jude continues to lead strides in conquering diverse childhood health challenges, from cancer and blood disorders to neurological diseases.

For more information, visit stjude.org and stay updated on the progress by following St. Jude on social media at @stjuderesearch.